axicabtagene ciloleucel,cyclophosphamide,fludarabine
gilead
['cml', 'dlbcl']
os improvement with anti-cd19 #cart in refractory or early-relapsed (&lt;1y) dlbcl. therapeutic algorithms will change in dlbcl! #17icml 
MD at @USAL | Internal Med student at @HematoCAUSA | #cytopath #cytometry and #lymphoma at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes